Clinical effect of levamisole therapy and its immunological control

S. Husz, J. Hunyadi, G. Berko, A. Dobozy, A. Kenderessy, N. Simon

Research output: Contribution to journalArticle

1 Citation (Scopus)


Studies have been performed on humoral and cellular immunoreactivities of 20 patients with different skin diseases, when common treatments applied for years were ineffective. The clinical results of Decaris (levamisolum) treatment were excellent in 12 and improved in 6 out of 20 patients after a six-month intermittent cure. This therapy resulted in a tendency toward normalization of several immunological characteristics such as complement level, relative amounts of different immunoglobulin bearing lymphocytes and the leucocyte migration inhibitory effect to PPD. This stimulatory action could be attributed to immunomodulation.

Original languageEnglish
Pages (from-to)569-574
Number of pages6
JournalDermatologische Monatsschrift
Issue number8
Publication statusPublished - Dec 1 1979


ASJC Scopus subject areas

  • Dermatology

Cite this